| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.58B | 57.01B | 51.94B | 44.80B | 41.96B | 39.18B |
| Gross Profit | 21.83B | 21.80B | 19.10B | 15.26B | 14.85B | 15.20B |
| EBITDA | 11.32B | 11.71B | 9.95B | 7.19B | 6.83B | 7.61B |
| Net Income | 7.58B | 7.83B | 6.58B | 4.51B | 4.10B | 5.02B |
Balance Sheet | ||||||
| Total Assets | 87.01B | 85.00B | 88.04B | 77.53B | 72.05B | 69.00B |
| Cash, Cash Equivalents and Short-Term Investments | 21.66B | 18.67B | 22.73B | 19.33B | 19.13B | 18.98B |
| Total Debt | 8.95B | 2.42B | 2.60B | 3.14B | 3.60B | 4.12B |
| Total Liabilities | 24.56B | 20.71B | 24.13B | 19.84B | 18.06B | 18.01B |
| Stockholders Equity | 59.36B | 60.97B | 61.09B | 55.16B | 51.59B | 48.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.31B | 6.36B | 2.59B | 2.59B | 250.00M |
| Operating Cash Flow | 0.00 | 5.74B | 8.91B | 4.09B | 3.64B | 5.62B |
| Investing Cash Flow | 0.00 | 261.00M | -2.23B | -1.65B | -1.22B | -9.25B |
| Financing Cash Flow | 0.00 | -8.15B | -3.35B | -2.29B | -2.30B | 308.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥46.91B | 14.35 | ― | 3.74% | 3.70% | 12.26% | |
75 Outperform | ¥143.86B | 9.90 | ― | 1.92% | 12.72% | 28.48% | |
69 Neutral | ¥87.55B | 13.57 | ― | 3.65% | 8.96% | -0.82% | |
67 Neutral | ¥910.80B | 9.02 | 0.85% | 2.36% | -0.03% | -89.02% | |
66 Neutral | ¥115.17B | 13.03 | ― | 3.53% | -0.58% | -46.15% | |
66 Neutral | ¥129.65B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |